Ottka C, Puurunen J, Müller E, Weber C, Klein R, Lohi H. Metabolic changes associated with two endocrine abnormalities in dogs: elevated fructosamine and low thyroxine.
Metabolomics 2022;
18:58. [PMID:
35859216 PMCID:
PMC9300525 DOI:
10.1007/s11306-022-01917-4]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/11/2022] [Accepted: 06/30/2022] [Indexed: 12/01/2022]
Abstract
INTRODUCTION
Metabolomics studies in canine endocrine abnormalities are sparse and basic information on these abnormalities must be generated.
OBJECTIVES
To characterize the metabolic changes associated with elevated fructosamine, reflecting poor glycemic control, and low thyroxine, a thyroid hormone controlling metabolism.
METHODS
Leftovers of clinical serum samples; 25 controls, 79 high fructosamine, and 47 low thyroxine, were analyzed using 1H NMR and differences were evaluated using Firth logistic regression.
RESULTS
Both high fructosamine and low thyroxine were associated with changes in concentrations of multiple metabolites, including glycoprotein acetyls and lipids.
CONCLUSION
These findings suggest promising makers for further research and clinical validation.
Collapse